Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes ; volume:20 ; number:1 ; day:26 ; month:2 ; year:2018 ; pages:1-12 ; date:12.2018
Arthritis Research & Therapy ; 20, Heft 1 (26.2.2018), 1-12, 12.2018
- Creator
-
de Moel, Emma C.
- Contributor
-
Derksen, Veerle F. A. M.
Stoeken, Gerrie
Trouw, Leendert A.
Bang, Holger
Goekoop, Robbert J.
Speyer, Irene
Huizinga, Tom W. J.
Allaart, Cornelia F.
Toes, René E. M.
van der Woude, Diane
SpringerLink (Online service)
- DOI
-
10.1186/s13075-018-1520-4
- URN
-
urn:nbn:de:101:1-2018091001031474161956
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- de Moel, Emma C.
- Derksen, Veerle F. A. M.
- Stoeken, Gerrie
- Trouw, Leendert A.
- Bang, Holger
- Goekoop, Robbert J.
- Speyer, Irene
- Huizinga, Tom W. J.
- Allaart, Cornelia F.
- Toes, René E. M.
- van der Woude, Diane
- SpringerLink (Online service)
Other Objects (12)
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity
Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
Autoantibody and metalloproteinase activity in early arthritis
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Rheumatoid arthritis
Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity
Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
Autoantibody and metalloproteinase activity in early arthritis
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Rheumatoid arthritis
Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis
Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity
Patients with ACPA-positive and ACPA-negative rheumatoid arthritis show different serological autoantibody repertoires and autoantibody associations with disease activity
Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis
CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
Autoantibody and metalloproteinase activity in early arthritis
Rheumatoid arthritis, as a clinical disease, but not rheumatoid arthritis-associated autoimmunity, is linked to cardiovascular events
Rheumatoid arthritis
Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis